- Home
- DCOM vs OGN Comparison
DCOM vs OGN Comparison
Compare DCOM & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DCOM | OGN |
|---|---|---|
| Founded | 1864 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | DCOM | OGN |
|---|---|---|
| Price | $32.73 | $7.94 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $36.40 | $11.63 |
| AVG Volume (30 Days) | 216.2K | ★ 4.6M |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 3.05% | 1.01% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.50 |
| Revenue | N/A | ★ $6,403,000,000.00 |
| Revenue This Year | $21.40 | N/A |
| Revenue Next Year | $12.62 | $1.65 |
| P/E Ratio | $14.81 | ★ $5.32 |
| Revenue Growth | N/A | ★ 2.24 |
| 52 Week Low | $23.25 | $6.18 |
| 52 Week High | $36.86 | $16.12 |
Technical Indicators
Market Signals| Indicator | DCOM | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 42.51 | 51.83 |
| Support Level | $29.19 | $6.48 |
| Resistance Level | $34.86 | $10.40 |
| Average True Range (ATR) | 1.17 | 0.38 |
| MACD | -0.47 | 0.00 |
| Stochastic Oscillator | 7.03 | 80.30 |
Price Performance
Historical ComparisonAbout DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.